Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2005-08-09
2005-08-09
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S009100, C424S009340, C424S009400, C424S009600, C514S005200, C514S006900, C514S007600, C514S008100, C514S021800, C530S381000, C530S395000, C530S408000, C530S409000, C530S410000
Reexamination Certificate
active
06926884
ABSTRACT:
The present invention provides a conjugate wherein GP (glycoprotein) Ib and a lipid are bonded via polyalkylene oxide. The present invention also provides a complex (GPIb lipid complex) containing this conjugate and a free lipid. The GPIb lipid complex is expected to have a potential for practical application in a wide range, as a platelet substitute, a pharmaceutical agent for the prophylaxis or treatment of angiopathy, vascular damage and thrombosis, a diagnostic for vWF deficiency and the like, a biological or medical reagent, a reagent for screening platelet aggregation suppressant or antithrombosis, and the like. The GPIb lipid complex of the present invention is also useful as a diagnostic for finding the location of vascular lesion or thrombus formation, or a therapeutic agent thereof. Moreover, the GPIb lipid complex of the present invention is also superior in retention property in blood, which enables continuous expression of a pharmacological action. The conjugate of the present invention is highly utilizable as an active ingredient of the GPIb lipid complex of the present invention.
REFERENCES:
patent: 5200510 (1993-04-01), Kumar et al.
patent: 5340727 (1994-08-01), Ruggeri et al.
patent: 6056973 (2000-05-01), Allen et al.
patent: 894807 (1999-02-01), None
patent: 99/58694 (1999-11-01), None
S. Zalipsky et al., “Poly(ethylene glycol)-grafted Liposomes with Oligopeptide or Oligosaccharide Ligands Appended to the Termini of the Polymer Chains”, Bioconjugate Chemistry, 1997, vol. 8, No. 2, pp. 111 to 8, abstract.
S, Zalipsky et al., “Synthesis of an End-Group Functionalized Polyethylene Glycol-Lipid Conjugate for Preparation of Polymer-Grafted Liposomes”, Bioconjugate Chemistry, 1993, vol. 4, No. 4, pp. 296 to 9, abstract, “Introduction”.
M.S. Webb et al., “Comparison of Different Hydrophobic Anchors Conjugated to Poly(ethylene glycol) : effects on the Pharmacokinetics of Liposomal Vincristine”, Biochimica et Biophysica ACTA, 1998, vol. 1372, No. 2, pp. 272 to 82, abstract; Table 1; Figs. 3 to 5.
Ikeda Yasuo
Mori Yoshiyuki
Mukai Hiromichi
Murata Mitsuru
Saito Hiroshi
Ikeda Yasuo
Mitsubishi Pharma Corporation
Russel Jeffrey Edwin
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
GPIb-lipid bond construct and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with GPIb-lipid bond construct and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GPIb-lipid bond construct and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3510559